| 0.8853 -0.315 (-26.23%) | 04-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.45 |
1-year : | 1.76 |
| Resists | First : | 1.24 |
Second : | 1.51 |
| Pivot price | 1.15 |
|||
| Supports | First : | 0.79 |
Second : | 0.66 |
| MAs | MA(5) : | 1.12 |
MA(20) : | 1.16 |
| MA(100) : | 1.59 |
MA(250) : | 1.53 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 50.6 |
D(3) : | 52.2  |
| RSI | RSI(14): 28.5 |
|||
| 52-week | High : | 4 | Low : | 0.54 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BEAT ] has closed below the lower bollinger band by 33.9%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 70.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 41 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.9 - 0.91 | 0.91 - 0.91 |
| Low: | 0.79 - 0.79 | 0.79 - 0.8 |
| Close: | 0.87 - 0.88 | 0.88 - 0.9 |
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Wed, 15 Apr 2026
Heartbeam, Inc. - Common Stock (NQ: BEAT - The Chronicle-Journal
Wed, 15 Apr 2026
BEAT: Titan Partners Leads Successful Stock Offering - GuruFocus
Tue, 14 Apr 2026
HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock - Business Wire
Tue, 14 Apr 2026
HeartBeam (BEAT) Launches Public Offering to Fund Growth Initiat - GuruFocus
Tue, 14 Apr 2026
HeartBeam (NASDAQ: BEAT) seeks funding with [●]‑share offering and pre‑funded warrants - Stock Titan
Tue, 14 Apr 2026
HeartBeam Announces Proposed Public Offering of Common Stock - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 41 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 19.9 (%) |
| Held by Institutions | 11.1 (%) |
| Shares Short | 4,080 (K) |
| Shares Short P.Month | 1,930 (K) |
| EPS | -0.63 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.05 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -289.8 % |
| Return on Equity (ttm) | -987.4 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.52 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -14 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -1.43 |
| PEG Ratio | 0 |
| Price to Book value | 14.75 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|